SLC2A1 and glioblastoma: Substitution of Cys209 for a serine residue resulted in decreased glycolysis and subsequent GBM tumour growth, indicating that GLUT1 palmitoylation by DHHC9 is involved in promoting GBM tumorigenesis through upregulating glycolytic processes (Zhang et al., 2021).